Jul 27, 2018 -
Jul 25, 2018 - Today's top stories: Trump/Juncker in trade talks; EU reciprocal tariff threat; and Sergio Marchionne passes away. If you are interested in listening to Wall Street Breakfast to start your day, look f
Jul 25, 2018 - Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on iTunes, Stitcher and SoundCloud (click the highlighted links). President Trump will sit down with European
Jul 25, 2018 - Let's see how these five pharma/biotech stocks are poised ahead of their scheduled results on Jul 26.
Jul 24, 2018 - The FDA grants fast track designation to Allergan's (AGN) AGN-241751, developed for the treatment of patients with major depressive disorder.
Jul 24, 2018 - Below is an updated look at the 35 largest S&P 500 companies. It's worth noting that recent gains have put four companies into the $800+ billion market cap club. Apple (NASDAQ:AAPL) is still on to
Jul 23, 2018 - Shares are trading at roughly a third of the original IPO price. Recent accumulation is indicative of further upside in the near term. Pessimism and past setbacks have led to an incredibly cheap valua
Jul 23, 2018 - Chickasaw Capital Management Llc Buys Williams Inc, Buckeye Partners LP, Renasant Corp, Sells Alerian MLP, Genuine Parts Co, Oaktree Capital Group LLC, Stocks: WMB,BPL,AGN,ENB,PFE,FB,LLY,RNST,FLR,MAA,AMLP,TDOC,, release date:Jul 23, 2018
Jul 23, 2018 - The FDA designates Allergan's (NYSE:AGN) Phase 2-stage AGN-241751 for Fast Track review for the treatment of major depressive disorder (MDD).The company acquired the NMDAR modulator from Aptin
Jul 23, 2018 - While Allergan's (AGN) Q2 sales are likely to be driven by new as well as established products like Botox and international growth, generic competition for some key products is expected to hurt sales.